期刊文献+

中青年高血压患者健康管理降压效果观察 被引量:1

Observation of antihypertensive effect of health management on hypertension in young and middle-aged patients
下载PDF
导出
摘要 目的:观察健康管理对中青年高血压患者的降压效果影响。方法:随机抽取2018年12月某研究院高血压患者140例,给予常规治疗。2019年3月对140例高血压患者进行血压、血脂及体重水平检查,并建立健康管理小组,采用常规治疗+健康管理指导。2019年9月比较健康管理前后降压效果。结果:管理后,患者收缩压及舒张压水平均下降,且血压达标率高于管理前,差异有统计学意义(P<0.05)。结论:对高血压患者进行健康管理,干预患者的不良生活方式和危险因素,有助于患者提升自我管理意识,有利于增强临床降压效果。 Objective:To explore the antihypertensive effect of health management on hypertension in young and middle-aged patients.Methods:140 in-service hypertensive patients in a research institute in December 2018 were randomly selected for routine treatment.In March 2019,140 patients with hypertension were examined for blood pressure,blood lipid and body weight,the health management team was established and routine treatment plus health management guidance was adopted.In September 2019,we compared the antihypertensive effects before and after treatment.Results:After management,both systolic and diastolic blood pressure decreased,and the compliance rate of blood pressure was higher than that before management,the difference was statistically significant(P<0.05).Conclusion:Health management of patients with hypertension and intervention of patients'bad lifestyle and risk factors will help patients improve their awareness of self-management and enhance the clinical effect of blood pressure reduction.
作者 周普 Zhou Pu(Clinic,Beijing Institute of Aeronautical Manufacturing Technology,Beijing 100024)
出处 《中国社区医师》 2021年第29期173-174,共2页 Chinese Community Doctors
关键词 高血压 健康管理 降压效果 Hypertension Health management Antihypertensive effect
  • 相关文献

参考文献7

二级参考文献62

  • 1周北凡.中国人群心血管病危险因素作用特点的前瞻性研究[J].中华流行病学杂志,2005,26(1):58-61. 被引量:122
  • 2国家心脏病中心.中国心血管病报告2014[M].北京:中国大百科全书出版社,2015.
  • 3Zhang X, Sun Z, Zheng L, et al. Prevalence of dyslipidemia and associated factors among the hypertensive rural Chinese population [J]. Arch Med Res, 2007,38(4):432-439.
  • 4李红娟,刘军,郭翔宇,等.中国门诊高血压患者合并多重心血管病危险因素现状:CONSIDER研究[J].中华心血管病杂志,2011,39增刊:252.
  • 5Zhao S, Wang Y, Mu Y, et al. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the dyslipidemia international study (DYSIS) [ J 1. Atherosclerosis, 2014,235 (2) :463-469.
  • 6Gao F, Zhou Y J, Hu DY, et al. Contemporary management and attainment of cholesterol targets for patients with dyslipidemia in China[Jl. PLoS One, 2013,8(4):e47681.
  • 7Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316099 white men. Multiple risk factor intervention trial research group[ Jl. Arch Intern Med, 1992,152( 1 ) :56-64.
  • 8Taylor WR. Hypertensive vasculm" disease and inflammation: mechanical and humoral mechanisms [ J]. Curr Hypertens Rep, 1999 ,I ( 1 ) :96-101.
  • 9Baudrand R, Pojoga LH, Vaidya A, et al. Statin use and adrenal aldosterone production in hypertensive and diabetic subjects [ J ]. Circulation, 2015, 132 ( 19 ) : 1825-1833.
  • 10CIRCULATIONAHA. 115. 016759. Wilson PW, D' Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories [ J ] . Circulation, 1998,97 ( 18 ) : 1837-1847.

共引文献683

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部